Ovarian cancer screening: are we making any progress?
- 1 September 2001
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Oncology
- Vol. 13 (5), 399-402
- https://doi.org/10.1097/00001622-200109000-00015
Abstract
Given the burden of suffering associated with the development of ovarian cancer and the clear survival gradient related to the stage of disease at diagnosis, there is much enthusiasm for the development of effective screening strategies aimed at early detection. To date, no evidence exists to justify mass population screening; however, emphasis on subpopulation screening, identification of novel serologic markers, and multimodality screening designs have provided hope that these refinements may eventually translate into a reduction in ovarian cancer mortality.Keywords
This publication has 19 references indexed in Scilit:
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerAmerican Journal of Human Genetics, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Ovarian carcinoma diagnosisCancer, 2000
- Delay in diagnosis of epithelial ovarian cancerInternational Journal of Gynecology & Obstetrics, 1996
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- Symptoms and diagnostic difficulties in ovarian epithelial cancerInternational Journal of Gynecology & Obstetrics, 1993
- Tribute to Patrick Steptoe: beginnings of laparoscopyHuman Reproduction, 1989
- Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancerInternational Journal of Cancer, 1988
- Symptomatology of ovarian cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1988
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983